Status:
UNKNOWN
Effect of Different Hemodialysis Modality on Adiponectin,Vascular Function and Clinical Prognosis
Lead Sponsor:
National Taiwan University Hospital
Conditions:
End-Stage Renal Disease
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
Adiponectin, an adipose tissue derived protein, with anti-inflammatory properties that is secreted from adipose tissue, is associated with insulin resistance. It has been shown to be a predictor of ca...
Detailed Description
Adiponectin, a cytokine with anti-inflammatory properties that is secreted from adipose tissue, is associated with insulin resistance (Horm Metab Res 34:469-474, 2002). The plasma adiponectin level ha...
Eligibility Criteria
Inclusion
- Clinical diagnosis on ESRD under regular maintenance hemodialysis, no active infection, no allergy to chosen AK, informed consent acquired
Exclusion
- Not ESRD, temporary HD, active infection, during admission, allergy to chosen AK, without informed consent
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00155363
Start Date
September 1 2004
Last Update
December 20 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital, Yun-Lin Branch
Douliu, Taiwan